Frank Hoebers

Dikutip oleh

	Semua	Sejak 2020
Kutipan	13085	7680
indeks-h	48	33
indeks-i10	110	91

1600

800

400

1200

20052006200720082009201020112012201320142015201620172018201920202021202220232024202542 56 40 83 101 102 131 157 180 221 378 599 858 1038 1226 1409 1519 1528 1445 1441 333

Akses publik

Lihat semua

66 artikel

2 artikel

tersedia

tidak tersedia

Berdasarkan pada mandat pendanaan

Pengarang bersama

Philippe LambinProfessor of Precision Medicine, Maastricht University & Scientist ULBEmail yang diverifikasi di maastrichtuniversity.nl
Andre DekkerProfessor of Clinical Data Science, MAASTRO Clinic, Maastricht University, GROW, Maastricht UMC+Email yang diverifikasi di maastro.nl
Ralph T.H. LeijenaarPhDEmail yang diverifikasi di maastrichtuniversity.nl
Hugo AertsDirector AI in Medicine (AIM) @ Harvard-MGB | Professor @ MaastrichtUEmail yang diverifikasi di dfci.harvard.edu
Emmanuel Rios VelazquezBusiness Development Manager | AI-Powered Lung Medical Image Analysis @ThironaEmail yang diverifikasi di thirona.eu
Wouter van ElmptMaastricht University Medical CentreEmail yang diverifikasi di maastro.nl
Michiel W van den BrekelNetherlands Cancer InstituteEmail yang diverifikasi di nki.nl
balm ahoogleraar uvaEmail yang diverifikasi di nki.nl
Esther TroostResident in Radiation OncologyEmail yang diverifikasi di uniklinikum-dresden.de
Rene MonshouwerRadboudumc, department of RadiotherapyEmail yang diverifikasi di radboudumc.nl
Catharina M.L. ZegersDepartment of Radiation Oncology (MAASTRO), GROW – Research Institute for Oncology and ReproductionEmail yang diverifikasi di maastro.nl
dhf rietveldEmail yang diverifikasi di amsterdamumc.nl
Leonard WeeMaastricht UniversityEmail yang diverifikasi di maastro.nl
Chintan ParmarAstraZeneca (past: PathAI, Novartis, Harvard-DFCI-BWH, ISI-Kolkata, DAIICT)Email yang diverifikasi di astrazeneca.com
Patrick GrossmannPh.D. Candidate conducting research at Harvard Medical School, Dana-Farber Cancer Institute, BWHEmail yang diverifikasi di jimmy.harvard.edu
Robert GilliesChair of Cancer Physiology, H. Lee Moffitt Cancer CenterEmail yang diverifikasi di moffitt.org
John QuackenbushHarvard T.H. Chan School of Public Health, Channing Division of Network Medicine, and Dana-FarberEmail yang diverifikasi di hsph.harvard.edu
Sara João CarvalhoBiostatistician @ Health iQEmail yang diverifikasi di medschl.cam.ac.uk
Harry BartelinkprofessorEmail yang diverifikasi di nki.nl
Cary OberijeEmail yang diverifikasi di maastrichtuniversity.nl

Ikuti

Frank Hoebers

Radiation Oncology (MAASTRO); Maastricht University; Brigham and Women's Hospital, Harvard Medical

Email yang diverifikasi di maastro.nl

Head and Neck Cancer Radiotherapy Machine Learning Artificial Intelligence


Judul Urutkan menurut kutipan Urutkan menurut tahun Urutkan menurut judul	Dikutip oleh Dikutip oleh	Tahun
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach HJWL Aerts, ER Velazquez, RTH Leijenaar, C Parmar, P Grossmann, ... Nature communications 5 (1), 4006, 2014	5232	2014
Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a … B O'Sullivan, SH Huang, J Su, AS Garden, EM Sturgis, K Dahlstrom, ... The Lancet Oncology 17 (4), 440-451, 2016	831	2016
Machine learning algorithms for outcome prediction in (chemo) radiotherapy: An empirical comparison of classifiers TM Deist, FJWM Dankers, G Valdes, R Wijsman, IC Hsu, C Oberije, ... Medical physics 45 (7), 3449-3459, 2018	312	2018
External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma RTH Leijenaar, S Carvalho, FJP Hoebers, HJWL Aerts, WJC Van Elmpt, ... Acta oncologica 54 (9), 1423-1429, 2015	241	2015
Rapid Learning health care in oncology’–an approach towards decision support systems enabling customised radiotherapy P Lambin, E Roelofs, B Reymen, ER Velazquez, J Buijsen, CML Zegers, ... Radiotherapy and Oncology 109 (1), 159-164, 2013	227	2013
CD44 expression predicts local recurrence after radiotherapy in larynx cancer MC de Jong, J Pramana, JE van der Wal, M Lacko, CJ Peutz-Kootstra, ... Clinical Cancer Research 16 (21), 5329-5338, 2010	221	2010
Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival MC Van Harten, FJP Hoebers, KW Kross, ED Van Werkhoven, ... Oral oncology 51 (3), 272-278, 2015	216	2015
Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients … G Thomas, S Ali, FJP Hoebers, KM Darcy, WH Rodgers, M Patel, ... Gynecologic oncology 108 (2), 317-325, 2008	215	2008
Data from NSCLC-radiomics HJWL Aerts, L Wee, E Rios Velazquez, RTH Leijenaar, C Parmar, ... (No Title), 2019	208	2019
Decision support systems for personalized and participative radiation oncology P Lambin, J Zindler, BGL Vanneste, L Van De Voorde, D Eekers, ... Advanced drug delivery reviews 109, 131-153, 2017	165	2017
Intra‐arterial versus intravenous chemoradiation for advanced head and neck cancer: results of a randomized phase 3 trial CRN Rasch, M Hauptmann, J Schornagel, O Wijers, J Buter, T Gregor, ... Cancer 116 (9), 2159-2165, 2010	164	2010
In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy: visual analysis in relation to treatment response M Kartachova, RLM Haas, RAV Olmos, FJP Hoebers, N van Zandwijk, ... Radiotherapy and oncology 72 (3), 333-339, 2004	155	2004
Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study RTH Leijenaar, M Bogowicz, A Jochems, FJP Hoebers, FWR Wesseling, ... The British journal of radiology 91 (1086), 20170498, 2018	145	2018
Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and … J Heukelom, O Hamming, H Bartelink, F Hoebers, J Giralt, T Herlestam, ... BMC cancer 13, 1-8, 2013	144	2013
HIF-1α, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors HLK Janssen, KMG Haustermans, D Sprong, G Blommestijn, I Hofland, ... International Journal of Radiation Oncology* Biology* Physics 54 (5), 1537-1549, 2002	144	2002
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014; 5: 4006 HJ Aerts, ER Velazquez, RT Leijenaar, C Parmar, P Grossmann, ...	133	2014
Tumor volume as prognostic factor in chemoradiation for advanced head and neck cancer JL Knegjens, M Hauptmann, FA Pameijer, AJ Balm, FJ Hoebers, ... Head & neck 33 (3), 375-382, 2011	133	2011
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5: 4006 HJ Aerts, ER Velazquez, RT Leijenaar, C Parmar, P Grossmann, ...	123	2014
Cervical esophageal cancer: a gap in cancer knowledge A Hoeben, J Polak, L Van De Voorde, F Hoebers, HI Grabsch, ... Annals of Oncology 27 (9), 1664-1674, 2016	110	2016
Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: A new concept for individually optimised treatment L Van den Bosch, A van der Schaaf, HP van der Laan, FJP Hoebers, ... Radiotherapy and Oncology 157, 147-154, 2021	109	2021

Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.

Artikel 1–20

Kutipan per tahun

Kutipan duplikat

Kutipan yang digabung

Tambahkan pengarang bersamaPengarang bersama

Ikuti

Dikutip oleh

Pengarang bersama